健康中国战略下我国商业健康保险定位价值、发展趋势及问题建议

马振涛, 文晓初

中国医疗保险 ›› 2025, Vol. 0 ›› Issue (3) : 92-106.

中国医疗保险 ›› 2025, Vol. 0 ›› Issue (3) : 92-106. DOI: 10.19546/j.issn.1674-3830.2025.3.012
商保天地

健康中国战略下我国商业健康保险定位价值、发展趋势及问题建议

  • 马振涛1,3, 文晓初2
作者信息 +

The Positioning, Value, Development Trend, Problems and Suggestions of Commercial Health Insurance in China Under the Healthy China Initiative

Author information +
文章历史 +

摘要

商业健康保险作为多层次医疗保障体系的重要组成部分,能够有效降低个人支付比例,合理分担医疗费用,进而促进医疗卫生服务总体水平的提升。近年来,我国商业健康保险在经历快速发展后,已迈入社商融合的新发展阶段。然而,商业健康保险的发展亦面临一系列挑战,包括产品创新不足、标准化体系缺失、政策支持力度有限、产业融合不深、数据共享困难以及理赔情况不理想等。鉴于此,本研究提出以下优化发展的建议:进一步明确商业健康保险定位范围,完善商业健康保险药品目录等标准体系;推动商业健康保险扩面提质,同时需更好地适应DRG/DIP支付方式改革要求;探索管理式医疗保险模式,推动保险行业与其他医疗健康领域的深度协作与融合发展。此外,还需强化政策激励与扶持力度,推进数据共享机制建设、优化服务流程,以助力健康中国战略的实施。

Abstract

As an important component of the multi-level healthcare security system in China, commercial health insurance can effectively reduce individual payment ratios, reasonably share medical expenses, and promote the overall improvement of medical and health services. In recent years, China's commercial health insurance has entered a new stage of social insurance-commercial insurance integration after rapid development. However, the development of commercial health insurance also faces a series of challenges, including insufficient product innovation, lack of standardization system, limited policy support, insufficient industry integration, difficulties in data sharing, and unsatisfactory claims. In view of this, this study proposes the following optimization and development suggestions. The positioning and scope of commercial health insurance should be further clarified, the standard system of commercial health insurance drug catalog should be improved, and the expansion and improvement of commercial health insurance should be promoted, better adapting to the requirements of DRG/DIP payment reform. The managed healthcare insurance model can be explored and deep collaboration and integrated development between the insurance industry and other healthcare sectors should be promoted. In addition, it is necessary to strengthen policy incentives and support, promote the construction of data sharing mechanisms, and optimize service processes to assist in the implementation of the Healthy China Initiative.

关键词

多层次医疗保障体系 / 基本医保 / 商业健康保险 / 健康中国 / 普惠保险

Key words

multi-level healthcare security system / basic medical insurance / commercial health insurance / Healthy China / inclusive insurance

引用本文

导出引用
马振涛, 文晓初. 健康中国战略下我国商业健康保险定位价值、发展趋势及问题建议[J]. 中国医疗保险. 2025, 0(3): 92-106 https://doi.org/10.19546/j.issn.1674-3830.2025.3.012
The Positioning, Value, Development Trend, Problems and Suggestions of Commercial Health Insurance in China Under the Healthy China Initiative[J]. China Health Insurance. 2025, 0(3): 92-106 https://doi.org/10.19546/j.issn.1674-3830.2025.3.012
中图分类号: F840.684    C913.7   

参考文献

[1] 杨红燕.世界各国主要医疗保障模式比较分析[J].医学与哲学,2002(05):1-5.
[2] 蔺淼,李水娥,丁锦希,等.新加坡政商合作型商业医疗保险对我国惠民保的启示[J].中国卫生经济,2023,42(07):91-96.
[3] 席子尧,林肯,邬欣仪.透视健康险行业九大趋势[EB/OL].(2024-02-18)[2024-12-15].https://finance.sina.com.cn/jjxw/2024-02-18/docinaimfyq9455730.shtml.
[4] 沙利文.2021年中国健康保险促进健康管理发展白皮书[R/OL].(2024-11-20)[2024-12-15].https://max.book118.com/html/2024/1118/6241211135011000.shtm.
[5] 郑秉文.商业保险参与多层次社会保障体系的方式、作用与评估——基于一个初步的分析框架[J].辽宁大学学报(哲学社会科学版),2019,47(06):1-21.
[6] 阎建军.政府基本医保对商业健康保险有“促进效应”吗?[J].金融评论,2018,10(02):1-14+122.
[7] AON.2022 Global medical rates report: global benefits[R/OL].(2022-03-09)[2024-12-15].https://max.book118.com/html/2022/0307/7116061166004100.shtm.
[8] 许闲,林陈威,尹轶帆.中国商业健康保险发展:演进与创新——基于2009—2022年中国医疗保险条款数据的分析[J].复旦学报(社会科学版),2023,65(05):181-190.
[9] 冯鹏程.商业健康保险40年[J].中国医院院长,2024,20(08):74-77.
[10] 许闲.商业健康保险与多层次医疗保障体系发展的几个核心问题[J].上海保险,2024(12):14-17.
[11] 南开大学卫生经济与医疗保障研究中心,北京圆心惠保科技有限公司.惠民保发展模式研究报告(2024)[R/OL].(2024-12-31)[2025-02-15].https://baijiahao.baidu.com/s?id=1819927386870413780&wfr=spider&for=pc.
[12] 国家医保局.“保障人民健康赋能经济发展”新闻发布会[EB/OL].(2025-01-17)[2025-02-10].http://www.nhsa.gov.cn/art/2025/1/17/art_52_15492.html.
[13] 马振涛,郎堃,林琛.商业健康保险嵌入多层次医疗保障体系:定位作用与改善进路[J].卫生经济研究,2024,41(11):32-35+39.
[14] 薛寒冰,王骅.我国DRG和DIP医保支付政策实践对商业健康保险发展影响分析[J].上海保险,2024(04):59-61.
[15] 姜鑫.医保控费、院外医疗需求增加商业健康险的“泼天富贵”来了?[N].经济观察报,2025-02-22.
[16] 王琬.中国商业健康保险:需求满足、市场法则与高质量发展[J].学术研究,2023(10):94-100+177.
[17] 李明肖.商业健康保险产品现状、发展制约因素及建议——以北京地区为例[J].保险理论与实践,2023(08):8-19.

基金

国家社科基金一般项目“数字技术赋能城市群协同治理问题研究”(22BGL269)

Accesses

Citation

Detail

段落导航
相关文章

/